((3R,5R)-5-phenyl-1-(3-phenylpropyl)piperidin-3-yl)methyl 2-(3-methyl-2,5-dioxopyrrolidin-1-yl)benzoate

ID: ALA465057

Chembl Id: CHEMBL465057

Max Phase: Preclinical

Molecular Formula: C33H36N2O4

Molecular Weight: 524.66

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CC(=O)N(c2ccccc2C(=O)OC[C@@H]2C[C@H](c3ccccc3)CN(CCCc3ccccc3)C2)C1=O

Standard InChI:  InChI=1S/C33H36N2O4/c1-24-19-31(36)35(32(24)37)30-17-9-8-16-29(30)33(38)39-23-26-20-28(27-14-6-3-7-15-27)22-34(21-26)18-10-13-25-11-4-2-5-12-25/h2-9,11-12,14-17,24,26,28H,10,13,18-23H2,1H3/t24?,26-,28+/m1/s1

Standard InChI Key:  HEKQABCBYYCZHJ-FKJWPSLMSA-N

Alternative Forms

  1. Parent:

    ALA465057

    ---

Associated Targets(Human)

CHRNB2 Tclin Neuronal acetylcholine receptor; alpha4/beta2 (3972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHRNA7 Neuronal acetylcholine receptor subunit alpha-7 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA3 Neuronal acetylcholine receptor subunit alpha-3 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.66Molecular Weight (Monoisotopic): 524.2675AlogP: 5.48#Rotatable Bonds: 9
Polar Surface Area: 66.92Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 10.01CX LogP: 5.92CX LogD: 3.36
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.27Np Likeness Score: -0.06

References

1. Huang J, Orac CM, McKay S, McKay DB, Bergmeier SC..  (2008)  The synthesis of 5-substituted ring E analogs of methyllycaconitine via the Suzuki-Miyaura cross-coupling reaction.,  16  (7): [PMID:18272373] [10.1016/j.bmc.2008.01.050]
2. Henderson BJ, Orac CM, Maciagiewicz I, Bergmeier SC, McKay DB..  (2012)  3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors.,  22  (4): [PMID:22285942] [10.1016/j.bmcl.2011.11.051]

Source